Xenbase may experience sporadic downtime from September 1st to September 3rd due to scheduled IT maintenance work.
We apologize for the inconvenience.
Click on this message to dismiss it.
Click here to close
Hello! We notice that you are using Internet Explorer, which is not supported by Xenbase and may cause the site to display incorrectly.
We suggest using a current version of Chrome,
FireFox, or Safari.
Physiol Rep
2013 Dec 08;17:e00165. doi: 10.1002/phy2.165.
Show Gene links
Show Anatomy links
Peptide transporter isoforms are discriminated by the fluorophore-conjugated dipeptides β-Ala- and d-Ala-Lys-N-7-amino-4-methylcoumarin-3-acetic acid.
Kottra G
,
Spanier B
,
Verri T
,
Daniel H
.
???displayArticle.abstract???
Peptide transporters of the SLC15 family are classified by structure and function into PEPT1 (low-affinity/high-capacity) and PEPT2 (high-affinity/low-capacity) isoforms. Despite the differences in kinetics, both transporter isoforms are reckoned to transport essentially all possible di- and tripeptides. We here report that the fluorophore-conjugated dipeptide derivatives β-Ala-Lys-N-7-amino-4-methylcoumarin-3-acetic acid (β-AK-AMCA) and d-Ala-Lys-N-7-amino-4-methylcoumarin-3-acetic acid (d-AK-AMCA) are transported by distinct PEPT isoforms in a species-specific manner. Transport of the fluorophore peptides was studied (1) in vitro after heterologous expression in Xenopus oocytes of PEPT1 and PEPT2 isoforms from different vertebrate species and of PEPT1 and PEPT2 transporters from Caenorhabditis elegans by using electrophysiological and fluorescence methods and (2) in vivo in C. elegans by using fluorescence methods. Our results indicate that both substrates are transported by the vertebrate "renal-type" and the C. elegans "intestinal-type" peptide transporter only. A systematic analysis among species finds four predicted amino acid residues along the sequence that may account for the substrate uptake differences observed between the vertebrate PEPT1/nematode PEPT2 and the vertebrate PEPT2/nematode PEPT1 subtype. This selectivity on basis of isoforms and species may be helpful in better defining the structure-function determinants of the proteins of the SLC15 family.
Figure 1. Currentâvoltage (I/V) relations induced by 1 mmol/L GQ (open circles) and by 1 mmol/L βâAKâAMCA (filled squares) in oocytes expressing (A) Caenorhabditis elegans PEPT1 (cePEPT1), (B) rabbit PEPT2 (rPEPT2), or (C) rabbit PEPT1 (rPEPT1). Please note the low, but significant transport current induced by βâAKâAMCA in cePEPT1, the higher current in rPEPT2 and the absence of βâAKâAMCAâinduced current in rPEPT1. Similar I/V relations have also been recorded in the other transporters listed in Table 1 (not shown).
Figure 2. Fluorescence (arbitrary units) induced by 3 h incubation in solutions containing 1 mmol/L βâAKâAMCA without or with 20 mmol/L GQ in oocytes expressing Caenorhabditis elegans (ce), human (h), rabbit (r), zebrafish (zf), mouse (m) PEPT1 and PEPT2 transporters, and rabbit chimeric transporters. NI, nonâinjected. Dark columns: without βâAKâAMCA; shaded columns: with 1 mmol/L βâAKâAMCA; open columns: with 1 mmol/L βâAKâAMCA + 20 mmol/L GQ. For details see Materials and Methods.
Figure 3. Timeâdependent uptake of βâAKâAMCA and dâAKâAMCA in wild type and peptide transporter deficient peptâ1(lg601) Caenorhabditis elegans. The animals were incubated for 10 min, 1 h, 2.5 h, and 5 h in medium containing 1 mmol/L βâ or dâAKâAMCA and representative images are shown. The fluorescent signal is mostly detectable in the intestinal epithelial cells. The anterior end of the nematodes in the representative images is positioned to the top and the asterix mark the terminal bulb of the pharynx (*). Scale bars indicate 50 μm.
Figure 4. Molecular phylogenetic analysis performed on vertebrate PEPT1 and PEPT2 and nematode PEPT1 and PEPT2 by maximum likelihood (ML) method. The evolutionary history was inferred by using the ML method based on the Whelan and Goldman (2001) model. The tree with the highest log likelihood (â37,196.4871) is shown. Initial tree(s) for the heuristic search were obtained automatically as follows. When the number of common sites was <100 or less than oneâfourth of the total number of sites, the maximum parsimony method was used; otherwise BIONJ method with MCL distance matrix was used. A discrete Gamma distribution was used to model evolutionary rate differences among sites (five categories; +G, parameter = 0.9600). The rate variation model allowed for some sites to be evolutionarily invariable ([+I], 9.1163% sites). The tree is drawn to scale, with branch lengths measured in the number of substitutions per site. The analysis involved 114 amino acid sequences. All positions with less than 95% site coverage were eliminated. That is, fewer than 5% alignment gaps, missing data, and ambiguous bases were allowed at any position. There were a total of 630 positions in the final data set. Evolutionary analyses were conducted in MEGA5 (Tamura et al. 2011).
Figure 5. Sequence comparison performed on rabbit, human, mouse and zebrafish PEPT1, rabbit, human and zebrafish PEPT2, Caenorhabditis elegans PEPT1, and C. elegans PEPT2 amino acid sequences. Multiple sequence alignment was obtained by Clustal Omega (1.2.0) using default parameters. Consensus is reported. Candidate amino acid substitutions along the sequence are indicated with an arrow highlighted in red.
Abe,
Conjugation of dipeptide to fluorescent dyes enhances its affinity for a dipeptide transporter (PEPT1) in human intestinal Caco-2 cells.
1999, Pubmed
Abe,
Conjugation of dipeptide to fluorescent dyes enhances its affinity for a dipeptide transporter (PEPT1) in human intestinal Caco-2 cells.
1999,
Pubmed
Allman,
Loss of the apical V-ATPase a-subunit VHA-6 prevents acidification of the intestinal lumen during a rhythmic behavior in C. elegans.
2009,
Pubmed
Bednarczyk,
NBD-TMA: a novel fluorescent substrate of the peritubular organic cation transporter of renal proximal tubules.
2000,
Pubmed
Biegel,
Structural requirements for the substrates of the H+/peptide cotransporter PEPT2 determined by three-dimensional quantitative structure-activity relationship analysis.
2006,
Pubmed
Biegel,
Three-dimensional quantitative structure-activity relationship analyses of beta-lactam antibiotics and tripeptides as substrates of the mammalian H+/peptide cotransporter PEPT1.
2005,
Pubmed
Boll,
Expression cloning and functional characterization of the kidney cortex high-affinity proton-coupled peptide transporter.
1996,
Pubmed
,
Xenbase
Boll,
Expression cloning of a cDNA from rabbit small intestine related to proton-coupled transport of peptides, beta-lactam antibiotics and ACE-inhibitors.
1994,
Pubmed
,
Xenbase
Brunaldi,
Fluorescence assays for measuring fatty acid binding and transport through membranes.
2007,
Pubmed
Chen,
Gene ablation for PEPT1 in mice abolishes the effects of dipeptides on small intestinal fluid absorption, short-circuit current, and intracellular pH.
2010,
Pubmed
Daniel,
Molecular and integrative physiology of intestinal peptide transport.
2004,
Pubmed
Dieck,
The peptide transporter PepT2 is expressed in rat brain and mediates the accumulation of the fluorescent dipeptide derivative beta-Ala-Lys-Nepsilon-AMCA in astrocytes.
1999,
Pubmed
Doki,
Structural basis for dynamic mechanism of proton-coupled symport by the peptide transporter POT.
2013,
Pubmed
Döring,
Importance of a small N-terminal region in mammalian peptide transporters for substrate affinity and function.
2002,
Pubmed
,
Xenbase
Döring,
Functional analysis of a chimeric mammalian peptide transporter derived from the intestinal and renal isoforms.
1996,
Pubmed
,
Xenbase
Fei,
cDNA structure, genomic organization, and promoter analysis of the mouse intestinal peptide transporter PEPT1.
2000,
Pubmed
,
Xenbase
Fei,
Two oligopeptide transporters from Caenorhabditis elegans: molecular cloning and functional expression.
1998,
Pubmed
,
Xenbase
Ganapathy,
Peptide transport in rabbit intestinal brush-border membrane vesicles studied with a potential-sensitive dye.
1985,
Pubmed
Ganapathy,
Differential recognition of beta -lactam antibiotics by intestinal and renal peptide transporters, PEPT 1 and PEPT 2.
1995,
Pubmed
Gebauer,
Three-dimensional quantitative structure-activity relationship analyses of peptide substrates of the mammalian H+/peptide cotransporter PEPT1.
2003,
Pubmed
Groneberg,
Renal assimilation of short chain peptides: visualization of tubular peptide uptake.
2002,
Pubmed
Groneberg,
Intestinal peptide transport: ex vivo uptake studies and localization of peptide carrier PEPT1.
2001,
Pubmed
Groneberg,
Distribution and function of the peptide transporter PEPT2 in normal and cystic fibrosis human lung.
2002,
Pubmed
Groneberg,
Direct visualization of peptide uptake activity in the central nervous system of the rat.
2004,
Pubmed
Guettou,
Structural insights into substrate recognition in proton-dependent oligopeptide transporters.
2013,
Pubmed
Iwao,
Differentiation of human induced pluripotent stem cells into functional enterocyte-like cells using a simple method.
2014,
Pubmed
Jørgensen,
Validation of a fluorescence-based high-throughput assay for the measurement of neurotransmitter transporter uptake activity.
2008,
Pubmed
Knütter,
A novel inhibitor of the mammalian peptide transporter PEPT1.
2001,
Pubmed
,
Xenbase
Kottra,
Bidirectional electrogenic transport of peptides by the proton-coupled carrier PEPT1 in Xenopus laevis oocytes: its asymmetry and symmetry.
2001,
Pubmed
,
Xenbase
Larsen,
QSAR models for the human H(+)/peptide symporter, hPEPT1: affinity prediction using alignment-independent descriptors.
2008,
Pubmed
Liang,
Human intestinal H+/peptide cotransporter. Cloning, functional expression, and chromosomal localization.
1995,
Pubmed
,
Xenbase
Liu,
Molecular cloning of PEPT 2, a new member of the H+/peptide cotransporter family, from human kidney.
1995,
Pubmed
Mason,
Novel fluorescence-based approaches for the study of biogenic amine transporter localization, activity, and regulation.
2005,
Pubmed
Meissner,
Deletion of the intestinal peptide transporter affects insulin and TOR signaling in Caenorhabditis elegans.
2004,
Pubmed
Newstead,
Towards a structural understanding of drug and peptide transport within the proton-dependent oligopeptide transporter (POT) family.
2011,
Pubmed
Romano,
High-affinity peptide transporter PEPT2 (SLC15A2) of the zebrafish Danio rerio: functional properties, genomic organization, and expression analysis.
2006,
Pubmed
,
Xenbase
Romano,
Teleost fish models in membrane transport research: the PEPT1(SLC15A1) H+-oligopeptide transporter as a case study.
2014,
Pubmed
Romano,
Functional expression of SLC15 peptide transporters in rat thyroid follicular cells.
2010,
Pubmed
Rühl,
Functional expression of the peptide transporter PEPT2 in the mammalian enteric nervous system.
2005,
Pubmed
Schwartz,
Binding and transport in norepinephrine transporters. Real-time, spatially resolved analysis in single cells using a fluorescent substrate.
2003,
Pubmed
Shu,
Mechanism of intestinal absorption and renal reabsorption of an orally active ace inhibitor: uptake and transport of fosinopril in cell cultures.
2001,
Pubmed
Solcan,
Alternating access mechanism in the POT family of oligopeptide transporters.
2012,
Pubmed
Son,
Characterization of carnosine uptake and its physiological function in human intestinal epithelial Caco-2 cells.
2004,
Pubmed
Spence,
Directed differentiation of human pluripotent stem cells into intestinal tissue in vitro.
2011,
Pubmed
,
Xenbase
Tamura,
MEGA5: molecular evolutionary genetics analysis using maximum likelihood, evolutionary distance, and maximum parsimony methods.
2011,
Pubmed
Theis,
Defining minimal structural features in substrates of the H(+)/peptide cotransporter PEPT2 using novel amino acid and dipeptide derivatives.
2002,
Pubmed
,
Xenbase
Theis,
Synthesis and characterization of high affinity inhibitors of the H+/peptide transporter PEPT2.
2002,
Pubmed
,
Xenbase
Toyobuku,
Enhanced delivery of drugs to the liver by adenovirus-mediated heterologous expression of the human oligopeptide transporter PEPT1.
2002,
Pubmed
Verri,
Molecular and functional characterisation of the zebrafish (Danio rerio) PEPT1-type peptide transporter.
2003,
Pubmed
,
Xenbase
Weitz,
Functional and structural characterization of a prokaryotic peptide transporter with features similar to mammalian PEPT1.
2007,
Pubmed
Wenzel,
Endogenous expression of the renal high-affinity H+-peptide cotransporter in LLC-PK1 cells.
1998,
Pubmed
Whelan,
A general empirical model of protein evolution derived from multiple protein families using a maximum-likelihood approach.
2001,
Pubmed
Wood,
Determination of pattern and fate in early embryos of Caenorhabditis elegans.
1988,
Pubmed
Xiang,
PEPT2-mediated transport of 5-aminolevulinic acid and carnosine in astrocytes.
2006,
Pubmed
Zhu,
Differential recognition of ACE inhibitors in Xenopus laevis oocytes expressing rat PEPT1 and PEPT2.
2000,
Pubmed
,
Xenbase